1. |
第十三届全国人民代表大会常务委员会第七次会议. 国务院关于财政医疗卫生资金分配和使用情况的报告. 2018.
|
2. |
European Network for Health Technology Assessment. HTA core model 3.0. 2016.
|
3. |
Chen Y, Zhao K, Liu G, et al. Health technology assessment to inform decision making in China: progress, challenges, and sustainability. BMJ, 2023, 381: e068910.
|
4. |
World Health Organization. Health technology assessment of medical devices. 2011.
|
5. |
National institute for Health and Care Excellence. Guide to the processes of technology appraisal. 2018.
|
6. |
National institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. 2013.
|
7. |
European Network for Health Technology Assessment. Assessment element tables for HTA core model application for pharmaceuticals 3.0. 2016.
|
8. |
European Network for Health Technology Assessment. Assessment element tables for HTA core model application for medical and surgical interventions 3.0. 2016.
|
9. |
European Network for Health Technology Assessment. Assessment element tables for HTA core model application for screening technologies 3.0. 2016.
|
10. |
European Network for Health Technology Assessment. Assessment element tables for HTA core model application for diagnostic technologies 3.0. 2016.
|
11. |
徐佩佩, 李汶睿, 曾力楠, 等. 国内外卫生技术评估方法学指南的系统评价. 中国药房, 2020, 31(12): 1500-1505.
|
12. |
National institute for Health and Care Excellence. Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma. 2020.
|
13. |
吴雪, 徐思敏, 戴泽琦, 等. 国内外卫生技术评估机构的概况性综述. 中国实验方剂学杂志, 2022, 28(20): 178-185.
|
14. |
World Health Organization. HTA country/area profile. 2021.
|
15. |
Sampietro CL, Martin J. Hospital-based health technology assessment. 2016.
|
16. |
Sampietro CL, Lach K, Cicchetti A, et al. The AdHopHTA handbook. 2015.
|
17. |
Health Intervention and Technology Assessment Program. Health technology assessment process guidelines. 2012.
|
18. |
Taylor R. Guidelines for authors of CADTH health technology assessment reports. 2003.
|
19. |
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. General method (version 7). 2022.
|
20. |
Oortwijn W, Broos P, Vondeling H, et al. Mapping of health technology assessment in selected countries. Int J Technol Assess Health Care, 2013, 29(4): 424-434.
|
21. |
Stretch L, Amend E. A guide to health technology assessment in the Palliser health region. 2005.
|
22. |
Radaelli G, Lettieri E, Masella C, et al. Implementation of EUnetHTA core Model® in Lombardia: the VTS framework. Int J Technol Assess Health Care, 2014, 30(1): 105-112.
|
23. |
O'Rourke B, Oortwijn W, Schuller T, et al. The new definition of health technology assessment: a milestone in international collaboration. Int J Technol Assess Health Care, 2020, 36(3): 187-190.
|
24. |
戴泽琦, 景城阳, 吴雪, 等. 国内外药品临床综合评价指标体系研究的系统评价. 中国循证医学杂志, 2023, 23(7): 776-782.
|
25. |
卢静雅, 沈建通, 赵齐园, 等. 医院卫生技术评估的流程与方法新进展. 中国循证医学杂志, 2019, 19(11): 1367-1372.
|
26. |
International Network of Agencies for Health Technology Assessment. A checklist for HTA reports (Version 4.0). 2007.
|
27. |
Chugh Y, Bahuguna P, Sohail A, et al. Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India. Appl Health Econ Health Policy, 2023, 21(1): 11-22.
|
28. |
Avşar TS, Yang X, Lorgelly P. How is the societal perspective defined in health technology assessment. guidelines from around the globe. Pharmacoeconomics, 2023, 41(2): 123-138.
|
29. |
Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ, 1986, 5(1): 1-30.
|
30. |
Jönsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ, 2009, 10(4): 357-359.
|
31. |
Arntsen KA, Blount LG, Dickerson BJ, et al. Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body. Int J Technol Assess Health Care, 2022, 38(1): e76.
|